SHOULDER INNOVATIONS, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
SHOULDER INNOVATIONS, INC. (SI) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$8.47 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-10
- SHOULDER INNOVATIONS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$8.47M.
- SHOULDER INNOVATIONS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$3.27M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | -$8.47M 10-K · filed 2026-03-10 |
| 2024-12-31 | -$3.27M 10-K · filed 2026-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |